COMMUNIQUÉS West-GlobeNewswire

Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA
09/10/2017
Oslo, Norway, 9 October 2017 The Board of Directors of Vistin Pharma ASA has decided to propose for an extraordinary general meeting an interim dividend of NOK 7.00 per share. Dividend amount: 7.00 per share Declared [...]
Vistin Pharma ASA : Proposal for Extraordinary Dividend
09/10/2017
Oslo, Norway, 9 October 2017 Norwegian pharmaceutical company Vistin Pharma ASA ("Vistin Pharma") announced today that the Board of Vistin Pharma will propose an extraordinary dividend of NOK 7.00 per share. On 2 [...]
ESPERITE N.V (ESP) WITH CRYOSAVE ENTERS THE UKRAINIAN MARKET AND FOSTERS ITS LEADERSHIP POSITION IN EUROPE
09/10/2017
CryoSave continues its European expansion through a partnership with the company Innovatsiyni Tekhnologiyi, based in Kiev. Amsterdam, The Netherlands - 9 October 2017 Increasing number of families throughout the world [...]
Medtronic Endurant(TM) II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX(TM) EndoAnchor(TM) System
09/10/2017
New Indication Expands Treatment Options for AAA Patients with Hostile Neck Anatomy DUBLIN - October 9, 2017 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) [...]
EDAP Signs Exclusive Agreement with Theraclion to Distribute Echopulse® HIFU Product in France
09/10/2017
EDAP to Market Echotherapy for ablation of breast fibroadenomas and benign thyroid nodules LYON, France, October 9, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the [...]
Summit Highlights Microbiome Preservation During Ridinilazole Treatment at ID Week 2017
09/10/2017
Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT HIGHLIGHTS MICROBIOME PRESERVATION DURING RIDINILAZOLE TREATMENT IN EXPLORATORY PHASE 2 CLINICAL TRIAL AT ID WEEK 2017 Oxford, UK, 9 October 2017 - Summit [...]
Novo Nordisk A/S - Share repurchase programme
09/10/2017
Bagsværd, Denmark, 9 October 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Immunicum AB (publ) Announces the Nomination Committee for AGM 2018
09/10/2017
Press release 9 October 2017 Immunicum AB (publ) Announces the Nomination Committee for AGM 2018 Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer [...]
' Large & Midcap Event ' de Paris a battu son record historique
09/10/2017
Paris, le 9 Octobre 2017 : La 17 e édition du 'Large & MidCap Event', créé et organisé par CF&B Communication, a été la plus vaste et la plus intense de son histoire. Plus de 390 dirigeants d'entreprises cotées [...]
'Large & MidCap Event' 2017, experienced its largest edition ever.
09/10/2017
Paris, October 9th, 2017 : The 2017 "Large & MidCap Event", created and organized by CF&B Communication, experienced its largest edition ever. Over 390 business leaders from Belgium, Finland, France, Greece, [...]
Ascom introduces 'Digistat Vitals', enabling single-entry vitals registration and scoring at the bedside
09/10/2017
The new application helps eliminate double documentation of vitals, scoring and associated errors; provides faster availability of vitals and clinical scores in Electronic Medical Records. BAAR, Switzerland, Oct. 09, [...]
AkzoNobel expands pharma salt production in Denmark
09/10/2017
October 9, 2017 AkzoNobel's Specialty Chemicals business has completed the expansion of a production site in Denmark which supplies essential pharmaceutical grade salt for the healthcare industry. Located in Mariager, [...]
Leading Sustainability Partners Danimer Scientific and PepsiCo Present Brand Collaboration Case Study at EFIB 2017
09/10/2017
Sustainability pioneers share innovation insights at largest biotechnology conference in Europe BAINBRIDGE, Ga. and PURCHASE, N.Y., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Industry leaders at Danimer Scientific , biopolymer [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
09/10/2017
FIT Biotech Oy Company release October 9, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Communiqué: Hilary Halper nommée Directeur Financier du groupe Essilor
09/10/2017
Hilary Halper nommée Directeur Financier du groupe Essilor Version PDF du communiqué Charenton-le-Pont, France (le 9 octobre 2017) - Essilor annonce la nomination de Hilary Halper au poste de Directeur Financier du [...]
News Release: Hilary Halper appointed CFO at Essilor
09/10/2017
Hilary Halper appointed CFO at Essilor PDF Version of the news release Charenton-le-Pont, France (October 9, 2017) - Essilor announces the appointment of Hilary Halper as Chief Financial Officer. Hilary Halper replaces [...]
Solon Eiendom ASA : Primary insider notification
09/10/2017
(Oslo, Norway, 6 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 13 666 shares in Solon Eiendom ASA at a price of NOK 18,7481. Following [...]
DSM Sinochem Pharmaceuticals Initiates Patent Litigation Against CSPC Pharmaceutical Group Ltd., Inner Mongolia Changsheng Pharmaceutical Company Ltd., and CSPC Zhangnuo Pharmaceutical (Shijiazhuan...
09/10/2017
DSM Sinochem Pharmaceuticals (DSP), the global leader in production and commercialization of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has filed a lawsuit against [...]
ThromboGenics announces publication in Experimental Eye Research of preclinical data supporting therapeutic potential of THR-317 in DR
09/10/2017
Press release Murine form of THR-317 able to reduce inflammation, vascular leakage and fibrosis in the mouse eye, without triggering a neurodegenerative response. Leuven, Belgium, 9 th October 2017 - ThromboGenics NV ( [...]

Pages